Correlation Between DexCom and Mangoceuticals, Common

Can any of the company-specific risk be diversified away by investing in both DexCom and Mangoceuticals, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Mangoceuticals, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DexCom Inc and Mangoceuticals, Common Stock, you can compare the effects of market volatilities on DexCom and Mangoceuticals, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Mangoceuticals, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Mangoceuticals, Common.

Diversification Opportunities for DexCom and Mangoceuticals, Common

-0.58

Correlation Coefficient

DexCom  Mangoceuticals, Common

Excellent diversification

The 3 months correlation between DexCom and Mangoceuticals, is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Mangoceuticals, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangoceuticals, Common and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Mangoceuticals, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangoceuticals, Common has no effect on the direction of DexCom i.e., DexCom and Mangoceuticals, Common go up and down completely randomly.

Pair Corralation between DexCom and Mangoceuticals, Common

Given the investment horizon of 90 days DexCom Inc is expected to generate 0.37 times more return on investment than Mangoceuticals, Common. However, DexCom Inc is 2.73 times less risky than Mangoceuticals, Common. It trades about 0.07 of its potential returns per unit of risk. Mangoceuticals, Common Stock is currently generating about -0.11 per unit of risk. If you would invest  7,236  in DexCom Inc on September 2, 2024 and sell it today you would earn a total of  563.00  from holding DexCom Inc or generate 7.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

DexCom Inc  vs.  Mangoceuticals, Common Stock

DexCom Inc

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, DexCom may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Mangoceuticals, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mangoceuticals, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with DexCom and Mangoceuticals, Common

The main advantage of trading using opposite DexCom and Mangoceuticals, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Mangoceuticals, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangoceuticals, Common will offset losses from the drop in Mangoceuticals, Common's long position.

The idea behind DexCom Inc and Mangoceuticals, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.